This panel yielded an AUC of 0.80, significantly surpassing the performance of IL-6 and IL-8 when used alone (AUC = 0.70 or 0.75, all p < 0.05) to distinguish WA cancer patients from their healthy counterparts (Figure 2) (Table 3). This evidence concerns the gene IL6 and cancer.